鼻ポリープによる慢性鼻炎: 混合内型におけるDupilumabの有効性
PubMedで要約を見る
まとめ
この要約は機械生成です。デュピルマブは,混合内型を含む鼻のポリープ (CRSwNP) を含む慢性鼻炎を効果的に治療します. 治療中に鼻中性粒子が増加した患者は,症状が少なく,生活の質が向上した.
科学分野
- 免疫学
- 耳鼻喉科
- 肺科
背景
- 鼻ポリープによる慢性鼻炎 (CRSwNP) は,混合T2および中性愛性エンドタイプを含む多様な炎症プロファイルを持つ複雑な疾患です.
- これらの内型を理解することは 効果的な治療戦略に不可欠です
研究 の 目的
- 異なる鼻内型におけるCRSwNP患者におけるドゥピルマブの実効性を評価する.
- 炎症プロファイルに基づいて治療結果を比較する.
主な方法
- デュピルマブで治療された31人のCRSwNP患者を対象とした前向きな観察研究.
- 評価には,内視鏡検査,鼻細胞検査,嗅覚機能 (VAS),血中エオシノフィール,生活の質 (SNOT-22),および発症直後の喘息コントロール (ACT) が含まれていた.
主要な成果
- ニュートロフィールとエオシノフィールの混合内型は,出血時点での患者の51. 6%に存在していた.
- 初期エンドタイプに関係なく,中性粒子の浸透量は3ヶ月後に患者の51. 6%で増加した.
- 中性粒子が増加した患者は,SNOT - 22とVASのスコアが最初は少なかったが,12ヶ月後に同様のレベルに達した.
結論
- デュピルマブはCRSwNPにおいて有効性を示し,中性細胞とエオシノフィルの混合内型を含む.
- ドピルマブ治療中に鼻内中性粒子が増加した患者のサブセットは,生活の質の改善と症状の軽減で明確な臨床プロファイルを示しています.
関連する概念動画
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

